首页> Molecular cancer therapeutics> SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors.

SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors.

导出 LinkOut

翻译打印收藏纠错

第一作者： Alba,Gonzalez-Junca

第一单位： Department of Research and Development, Senti Biosciences, Inc., South San Francisco, California. alba.gonzalez@sentibio.com.

作者： Alba,Gonzalez-Junca ^[1] ; Frances D,Liu ^[2] ; Archana S,Nagaraja ^[2] ; Alyssa,Mullenix ^[2] ; Chen-Ting,Lee ^[2] ; Russell M,Gordley ^[2] ; Daniel O,Frimannsson ^[2] ; Ori,Maller ^[2] ; Brian S,Garrison ^[2] ; Dharini,Iyer ^[3] ; Anissa,Benabbas ^[2] ; Tiffany A,Truong ^[2] ; Allison,Quach ^[2] ; Mengxi,Tian ^[2] ; Rowena,Martinez ^[2] ; Rishi,Savur ^[2] ; Alyssa,Perry-McNamara ^[2] ; Denny,Nguyen ^[2] ; Niran,Almudhfar ^[2] ; Carmina,Blanco ^[4] ; Christina,Huynh ^[4] ; Asish,Nand ^[4] ; Yu-An E,Lay ^[4] ; Ashita,Magal ^[4] ; Sravani,Mangalampalli ^[4] ; Philip J,Lee ^[4] ; Timothy K,Lu ^[2] ; Gary,Lee ^[2]

作者单位： Department of Research and Development, Senti Biosciences, Inc., South San Francisco, California. alba.gonzalez@sentibio.com. ^[1] Department of Research and Development, Senti Biosciences, Inc., South San Francisco, California. ^[2] Department of Research and Development, Senti Biosciences, Inc., South San Francisco, California.;Department of Technology and Operations, Senti Biosciences, Inc., South San Francisco, California. ^[3] Department of Technology and Operations, Senti Biosciences, Inc., South San Francisco, California. ^[4]